ArticleMolecular cancer2007

A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines.

Mohammad Hasanuzzaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.